Contact
Please use this form to send email to PR contact of this press release:
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma
TO:
Please use this form to send email to PR contact of this press release:
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma
TO: